Gerard Gould | VP, IR |
Christopher Simon | CEO, President & Director |
William Burke | CFO & EVP |
Anthony Petrone | Jefferies |
Andrew Brackmann | William Blair & Company |
Varun Kuchibhatla | Morgan Stanley |
David Turkaly | JMP Securities |
Good day, ladies and gentlemen, and welcome to the Second Quarter 2019 Haemonetics Corporation Earnings Conference Call. [Operator Instructions].
As a reminder, this conference call may be recorded. I would now like to turn the conference over to Gerry Gould, Vice President, Investor Relations.
You may begin.